In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
2024-2028 Global Herpes Testing (Simplex I/II, Type VI) in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Regions and Countries Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, ... Read More
-
Asia Cervical Cancer Screening Market, Size, Forecast 2024-2032, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... billion by 2032 up from US$ 3.76 billion in 2023. This expected growth is going to be a CAGR 4.23% between 2024 and 2032. Women health and preventive medicine has been of most concern resulting ... Read More
-
Hereditary Testing
... at a CAGR of 6.1% over the analysis period 2023-2030. Preimplantation Genetic Diagnosis & Screening Test, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$4.6 Billion ... Read More
-
Immunofluorescence Assays
... at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence Assays Reagents, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.8 Billion by the end ... Read More
-
In Vitro Diagnostics
... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. In Vitro Diagnostics Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and ... Read More
-
Automated Immunoassay Analyzers
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the ... Read More
-
Hemostasis and Tissue Sealing Agents
... is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Topical Hemostat, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More
-
Microbiology Culture
... at a CAGR of 3.9% over the analysis period 2023-2030. Eukaryotic Culture, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.2 Billion by the end of ... Read More
-
Clostridium Diagnostics
... at a CAGR of 14.1% over the analysis period 2023-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$9.1 Billion by the end of ... Read More
-
High-Density Multiplexed Diagnostic Assays
... reach US$5.5 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2023-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More
-
Human Papillomavirus (HPV) Testing
... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More
-
Specimen Validity Testing
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Specimen Validity Testing Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$2.9 ... Read More
-
Helicobacter Pylori Diagnostics
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by ... Read More
-
Clinical Risk Grouping Solutions
... 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.1 Billion ... Read More
-
Toxicology Testing Services
... at a CAGR of 8.4% over the analysis period 2023-2030. In Vivo Method, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$10.2 Billion by the end ... Read More
-
In Vitro Diagnostics (IVD) Quality Control
... reach US$1.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Clinical Chemistry Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and ... Read More
-
Multiplex Assays
... at a CAGR of 6.4% over the analysis period 2023-2030. Protein Assays, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.5 Billion by the end of ... Read More
-
Mycotoxin Testing
... at a CAGR of 5.9% over the analysis period 2023-2030. Spectroscopy- & Chromatography-Based Testing, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.6 Billion by the ... Read More
-
Mycoplasma Testing
... at a CAGR of 8.5% over the analysis period 2023-2030. Mycoplasma Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$940.8 Million ... Read More
-
Immunoprotein Diagnostic Testing
... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Immunoglobulin Diagnostic, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$6.4 Billion by ... Read More
-
Hepatitis Therapeutics
... at a CAGR of 3.7% over the analysis period 2023-2030. Hepatitis C Disease Type, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$17.8 Billion by the ... Read More
-
Paper Diagnostics
... at a CAGR of 6.6% over the analysis period 2023-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the ... Read More
-
Heparin
... of 2.8% over the analysis period 2023-2030. Low Molecular Weight Heparin (LMWH), one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$5.9 Billion by the end of ... Read More
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
Research Assistance
